146 related articles for article (PubMed ID: 4062337)
1. Plasmapheresis in severe drug-induced toxic epidermal necrolysis.
Kamanabroo D; Schmitz-Landgraf W; Czarnetzki BM
Arch Dermatol; 1985 Dec; 121(12):1548-9. PubMed ID: 4062337
[TBL] [Abstract][Full Text] [Related]
2. Intravenous immunoglobulins and plasmapheresis combined treatment in patients with severe toxic epidermal necrolysis: preliminary report.
Lissia M; Figus A; Rubino C
Br J Plast Surg; 2005 Jun; 58(4):504-10. PubMed ID: 15897036
[TBL] [Abstract][Full Text] [Related]
3. Status of plasmapheresis for the treatment of toxic epidermal necrolysis in Japan.
Yamada H; Takamori K
Ther Apher Dial; 2008 Oct; 12(5):355-9. PubMed ID: 18937717
[TBL] [Abstract][Full Text] [Related]
4. Beneficial therapeutic effect of plasmapheresis after unsuccessful treatment with corticosteroids in two patients with severe toxic epidermal necrolysis.
Szczeklik W; Nowak I; Seczynska B; Sega A; Krolikowski W; Musial J
Ther Apher Dial; 2010 Jun; 14(3):354-7. PubMed ID: 20609191
[TBL] [Abstract][Full Text] [Related]
5. Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants.
Wolkenstein P; Charue D; Laurent P; Revuz J; Roujeau JC; Bagot M
Arch Dermatol; 1995 May; 131(5):544-51. PubMed ID: 7741540
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of plasmapheresis for the treatment of severe toxic epidermal necrolysis: Is cytokine expression analysis useful in predicting its therapeutic efficacy?
Narita YM; Hirahara K; Mizukawa Y; Kano Y; Shiohara T
J Dermatol; 2011 Mar; 38(3):236-45. PubMed ID: 21342225
[TBL] [Abstract][Full Text] [Related]
7. [Lyell's syndrome: proposal for a therapeutic protocol].
Posadinu MA; Sanna E; Canu V; Ciccarese M; Pala PG; Cossu M
G Ital Nefrol; 2012; 29 Suppl 54():S147-8. PubMed ID: 22388849
[TBL] [Abstract][Full Text] [Related]
8. Management of toxic epidermal necrolysis and related syndromes.
Mukasa Y; Craven N
Postgrad Med J; 2008 Feb; 84(988):60-5. PubMed ID: 18322124
[TBL] [Abstract][Full Text] [Related]
9. Intense pulsed light treatment of persistent facial hypermelanosis following drug-induced toxic epidermal necrolysis.
Paquet P; Piérard GE
Dermatol Surg; 2004 Dec; 30(12 Pt 2):1522-5. PubMed ID: 15606831
[TBL] [Abstract][Full Text] [Related]
10. [Drug induced toxic epidermal necrolysis].
Takimoto R; Takamori K
Nihon Rinsho; 2004 May; 62 Suppl 5():515-8. PubMed ID: 15197975
[No Abstract] [Full Text] [Related]
11. Toxic epidermal necrolysis due to administration of celecoxib (Celebrex).
Friedman B; Orlet HK; Still JM; Law E
South Med J; 2002 Oct; 95(10):1213-4. PubMed ID: 12425513
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effect of plasma exchange in the treatment of toxic epidermal necrolysis: a series of four cases.
Koštál M; Bláha M; Lánská M; Koštálová M; Bláha V; Štepánová E; Malý J
J Clin Apher; 2012; 27(4):215-20. PubMed ID: 22407895
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of treatments and deceased cases of severe adverse drug reactions--analysis of 46 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis].
Yamane Y; Aihara M; Tatewaki S; Matsukura S; Kanbara T; Yamakawa Y; Ikezawa Z
Arerugi; 2009 May; 58(5):537-47. PubMed ID: 19487835
[TBL] [Abstract][Full Text] [Related]
14. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides].
Aberer W; Stingl G; Wolff K
Hautarzt; 1982 Sep; 33(9):484-90. PubMed ID: 7174320
[TBL] [Abstract][Full Text] [Related]
15. Toxic epidermal necrolysis: analysis of clinical course and SCORTEN-based comparison of mortality rate and treatment modalities in Korean patients.
Kim KJ; Lee DP; Suh HS; Lee MW; Choi JH; Moon KC; Koh JK
Acta Derm Venereol; 2005; 85(6):497-502. PubMed ID: 16396796
[TBL] [Abstract][Full Text] [Related]
16. [Plasmapheresis in the therapy of drug-induced toxicoderma].
Davatdarova MM
Vestn Dermatol Venerol; 1990; (7):32-4. PubMed ID: 2147802
[TBL] [Abstract][Full Text] [Related]
17. Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis.
Stella M; Clemente A; Bollero D; Risso D; Dalmasso P
Burns; 2007 Jun; 33(4):452-9. PubMed ID: 17475410
[TBL] [Abstract][Full Text] [Related]
18. [Lyell syndrome in Senegal: responsibility of thiacetazone].
Mame Thierno D; On S; Thierno Ndiaye S; Ndiaye B
Ann Dermatol Venereol; 2001 Dec; 128(12):1305-7. PubMed ID: 11908132
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of plasmapheresis in the treatment of refractory toxic epidermal necrolysis-like acute cutaneous lupus erythematosus.
Simsek I; Cinar M; Erdem H; Pay S; Meric C; Dinc A
Lupus; 2008 Jun; 17(6):605-6. PubMed ID: 18539717
[No Abstract] [Full Text] [Related]
20. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
